Study Information

Alliance Study ID: A221801

NCT Study ID (ClinicalTrials.gov): NCT05379153

Alliance Committee: Cancer Control

Disease or Cancer Type: Breast Cancer

Alliance Study Chair: Maryam Lustberg, MD, MPH

Status: RECRUITING


Study Description

This phase III trial tests whether vaginal fractional CO2 laser therapy works in treating vaginal dryness in breast cancer survivors. Vaginal dryness can be commonly experienced with normal aging, with menopause, or come about from medications used to treat breast cancer such as chemotherapy or endocrine therapies like tamoxifen or aromatase inhibitors. Vaginal fractional CO2 laser therapy may help reduce vaginal dryness.

Related Publications

For publications related to this and other clinical trials, visit the Alliance Publications Application.

Locations (2)

Trinity Health IHA – Obstetrics and Gynecology West Arbor
Ann Arbor, Michigan 48103
United States

Ohio State University Comprehensive Cancer Center
Columbus, Ohio 43210
United States

Data Sources & Contacts

Related Alliance Trials